SPIO-based MR lymphangiography contrast agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SPIO-based MR lymphangiography contrast agent, covering 2010-01-27 to 2010-01-27. Get the full timeline:
Most recent: Clinical Trial Update: A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast [NA]